{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:34:46Z","timestamp":1790908486289,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T00:00:00Z","timestamp":1553126400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81660154"],"award-info":[{"award-number":["81660154"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81460162"],"award-info":[{"award-number":["81460162"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12944-019-1004-9","type":"journal-article","created":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T11:03:18Z","timestamp":1553252598000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Adenovirus type 36 regulates adipose stem cell differentiation and glucolipid metabolism through the PI3K\/Akt\/FoxO1\/PPAR\u03b3 signaling pathway"],"prefix":"10.1186","volume":"18","author":[{"given":"Yi","family":"Jiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfei","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiliyasi","family":"Aisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuerbiye","family":"Nuermaimaiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7280-3767","authenticated-orcid":false,"given":"Yaqun","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,21]]},"reference":[{"key":"1004_CR1","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/sj.ijo.0802830","volume":"29","author":"RL Atkinson","year":"2005","unstructured":"Atkinson RL, Dhurandhar NV, Allison DB, Bowen RL, Israel BA, Albu JB, Augustus AS. Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids. Int J Obes. 2005;29:281\u20136.","journal-title":"Int J Obes"},{"key":"1004_CR2","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/S1473-3099(11)70274-2","volume":"11","author":"NV Dhurandhar","year":"2011","unstructured":"Dhurandhar NV. A framework for identification of infections that contribute to human obesity. Lancet Infect Dis. 2011;11:963\u20139.","journal-title":"Lancet Infect Dis"},{"key":"1004_CR3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jdiacomp.2012.09.006","volume":"27","author":"NV Dhurandhar","year":"2013","unstructured":"Dhurandhar NV. Insulin sparing action of adenovirus 36 and its E4orf1 protein. J Diabetes Complicat. 2013;27:191\u20139.","journal-title":"J Diabetes Complicat"},{"issue":"Suppl 2","key":"1004_CR4","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.33549\/physiolres.933130","volume":"64","author":"V Hainer","year":"2015","unstructured":"Hainer V, Zamrazilova H, Kunesova M, Bendlova B, Aldhoon-Hainerova I. Obesity and infection: reciprocal causality. Physiol Res. 2015;64(Suppl 2):S105\u201319.","journal-title":"Physiol Res"},{"key":"1004_CR5","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.4067\/s0034-98872017000801054","volume":"145","author":"F Villavicencio","year":"2017","unstructured":"Villavicencio F, Valladares M. The potential contribution of adenovirus 36 to the development of obesity. Rev Med Chil. 2017;145:1054\u20139.","journal-title":"Rev Med Chil"},{"key":"1004_CR6","doi-asserted-by":"crossref","unstructured":"Sapunar J, Fonseca L, Molina V, Ortiz E, Barra MI, Reimer C, Charles M, Schneider C, Ortiz M, Brito R, et al: Adenovirus 36 seropositivity is related to obesity risk, glycemic control, and leptin levels in Chilean subjects. 2019.","DOI":"10.1038\/s41366-019-0321-4"},{"key":"1004_CR7","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.biochi.2015.12.002","volume":"121","author":"V Hegde","year":"2016","unstructured":"Hegde V, Na HN, Dubuisson O, Burke SJ, Collier JJ, Burk D, Mendoza T, Dhurandhar NV. An adenovirus-derived protein: a novel candidate for anti-diabetic drug development. Biochimie. 2016;121:140\u201350.","journal-title":"Biochimie"},{"key":"1004_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.micpath.2017.04.034","volume":"108","author":"B Kocazeybek","year":"2017","unstructured":"Kocazeybek B, Dinc HO, Ergin S, Saribas S, Ozcabi BT, Cizmecigil U, Altan E, Atalik K, Yuksel P, Taner Z, et al. Evaluation of Adenovirus-36 (Ad-36) antibody seropositivity and adipokine levels in obese children. Microb Pathog. 2017;108:27\u201331.","journal-title":"Microb Pathog"},{"key":"1004_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/sj.ijo.0803366","volume":"31","author":"SD Vangipuram","year":"2007","unstructured":"Vangipuram SD, Yu M, Tian J, Stanhope KL, Pasarica M, Havel PJ, Heydari AR, Dhurandhar NV. Adipogenic human adenovirus-36 reduces leptin expression and secretion and increases glucose uptake by fat cells. Int J Obes. 2007;31:87\u201396.","journal-title":"Int J Obes"},{"key":"1004_CR10","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/sj.ijo.0803748","volume":"32","author":"PM Rogers","year":"2008","unstructured":"Rogers PM, Fusinski KA, Rathod MA, Loiler SA, Pasarica M, Shaw MK, Kilroy G, Sutton GM, McAllister EJ, Mashtalir N, et al. Human adenovirus Ad-36 induces adipogenesis via its E4 orf-1 gene. Int J Obes. 2008;32:397\u2013406.","journal-title":"Int J Obes"},{"key":"1004_CR11","doi-asserted-by":"publisher","first-page":"e23394","DOI":"10.1371\/journal.pone.0023394","volume":"6","author":"EJ Dhurandhar","year":"2011","unstructured":"Dhurandhar EJ, Dubuisson O, Mashtalir N, Krishnapuram R, Hegde V, Dhurandhar NV. E4orf1: a novel ligand that improves glucose disposal in cell culture. PLoS One. 2011;6:e23394.","journal-title":"PLoS One"},{"key":"1004_CR12","doi-asserted-by":"publisher","first-page":"e1004102","DOI":"10.1371\/journal.ppat.1004102","volume":"10","author":"K Kong","year":"2014","unstructured":"Kong K, Kumar M, Taruishi M, Javier RT. The human adenovirus E4-ORF1 protein subverts discs large 1 to mediate membrane recruitment and dysregulation of phosphatidylinositol 3-kinase. PLoS Pathog. 2014;10:e1004102.","journal-title":"PLoS Pathog"},{"key":"1004_CR13","doi-asserted-by":"publisher","first-page":"31515","DOI":"10.1074\/jbc.272.50.31515","volume":"272","author":"M Andjelkovi\u0107","year":"1997","unstructured":"Andjelkovi\u0107 M, Alessi DR, Meier R, Fernandez A, Lamb NJ, Frech M, Cron P, Cohen P, Lucocq JM, Hemmings BA. Role of translocation in the activation and function of protein kinase B. J Biol Chem. 1997;272:31515\u201324.","journal-title":"J Biol Chem"},{"key":"1004_CR14","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3390\/nu10020130","volume":"10","author":"S Nagai","year":"2018","unstructured":"Nagai S, Matsumoto C, Shibano M, Fujimori K. Suppression of fatty acid and triglyceride synthesis by the flavonoid Orientin through decrease of C\/EBP\u03b4 expression and inhibition of PI3K\/Akt-FOXO1 signaling in adipocytes. Nutrients. 2018;10:130.","journal-title":"Nutrients"},{"key":"1004_CR15","doi-asserted-by":"publisher","first-page":"19881","DOI":"10.1074\/jbc.M600320200","volume":"281","author":"M Armoni","year":"2006","unstructured":"Armoni M, Harel C, Karni S, Chen H, Bar-Yoseph F, Ver MR, Quon MJ, Karnieli E. FOXO1 represses peroxisome proliferator-activated receptor-gamma1 and -gamma2 gene promoters in primary adipocytes. A novel paradigm to increase insulin sensitivity. J Biol Chem. 2006;281:19881\u201391.","journal-title":"J Biol Chem"},{"key":"1004_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11010-016-2912-x","volume":"428","author":"Y Jiao","year":"2016","unstructured":"Jiao Y, Aisa Y, Liang X, Nuermaimaiti N, Xian G, Zhang Z, Guan Y. Regulation of PPAR\u03b3 and CIDEC expression by adenovirus 36 in adipocyte differentiation. Mol Cell Biochem. 2016;428:1\u20138.","journal-title":"Mol Cell Biochem"},{"key":"1004_CR17","doi-asserted-by":"crossref","unstructured":"Li M, Tang Y, Wu L, Mo F, Wang X, Li H, Qi R, Zhang H, Srivastava A, Ling C: The hepatocyte-specific HNF4alpha\/miR-122 pathway contributes to iron overload-mediated hepatic inflammation. 2017, 130:1041\u20131051.","DOI":"10.1182\/blood-2016-12-755967"},{"key":"1004_CR18","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/0092-8674(94)90006-X","volume":"79","author":"P Tontonoz","year":"1994","unstructured":"Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell. 1994;79:1147\u201356.","journal-title":"Cell"},{"key":"1004_CR19","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1146\/annurev-immunol-031210-101322","volume":"29","author":"MF Gregor","year":"2011","unstructured":"Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011;29:415\u201345.","journal-title":"Annu Rev Immunol"},{"key":"1004_CR20","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.3390\/v7072787","volume":"7","author":"E Ponterio","year":"2015","unstructured":"Ponterio E, Gnessi L. Adenovirus 36 and obesity: an overview. Viruses. 2015;7:3719\u201340.","journal-title":"Viruses"},{"key":"1004_CR21","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/sj.ijo.0801319","volume":"24","author":"NV Dhurandhar","year":"2000","unstructured":"Dhurandhar NV, Israel BA, Kolesar JM, Mayhew GF, Cook ME, Atkinson RL. Increased adiposity in animals due to a human virus. Int J Obes Relat Metab Disord. 2000;24:989\u201396.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"1004_CR22","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/MED.0000000000000093","volume":"21","author":"H Bays","year":"2014","unstructured":"Bays H. Central obesity as a clinical marker of adiposopathy; increased visceral adiposity as a surrogate marker for global fat dysfunction. Curr Opin Endocrinol Diabetes Obes. 2014;21:345\u201351.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"1004_CR23","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.2337\/db11-0219","volume":"60","author":"AH Ali","year":"2011","unstructured":"Ali AH, Koutsari C, Mundi M, Stegall MD, Heimbach JK, Taler SJ, Nygren J, Thorell A, Bogachus LD, Turcotte LP, et al. Free fatty acid storage in human visceral and subcutaneous adipose tissue: role of adipocyte proteins. Diabetes. 2011;60:2300\u20137.","journal-title":"Diabetes"},{"key":"1004_CR24","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.biochi.2015.10.024","volume":"125","author":"P Morigny","year":"2016","unstructured":"Morigny P, Houssier M, Mouisel E, Langin D. Adipocyte lipolysis and insulin resistance. Biochimie. 2016;125:259\u201366.","journal-title":"Biochimie"},{"key":"1004_CR25","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/978-3-319-48382-5_12","volume":"960","author":"D Yazici","year":"2017","unstructured":"Yazici D, Sezer H. Insulin resistance, obesity and lipotoxicity. Adv Exp Med Biol. 2017;960:277\u2013304.","journal-title":"Adv Exp Med Biol"},{"key":"1004_CR26","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.cmet.2013.03.008","volume":"17","author":"T Tchkonia","year":"2013","unstructured":"Tchkonia T, Thomou T, Zhu Y, Karagiannides I, Pothoulakis C, Jensen MD, Kirkland JL. Mechanisms and metabolic implications of regional differences among fat depots. Cell Metab. 2013;17:644\u201356.","journal-title":"Cell Metab"},{"key":"1004_CR27","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1016\/j.jacc.2016.07.788","volume":"68","author":"B Gaborit","year":"2016","unstructured":"Gaborit B, Dutour A. Ectopic fat deposition and diabetes mellitus. J Am Coll Cardiol. 2016;68:2595.","journal-title":"J Am Coll Cardiol"},{"key":"1004_CR28","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.4161\/15384101.2014.965977","volume":"13","author":"P Zou","year":"2014","unstructured":"Zou P, Liu L, Zheng L, Liu L, Stoneman RE, Cho A, Emery A, Gilbert ER, Cheng Z. Targeting FoxO1 with AS1842856 suppresses adipogenesis. Cell Cycle. 2014;13:3759\u201367.","journal-title":"Cell Cycle"},{"key":"1004_CR29","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1042\/bj20040167","volume":"380","author":"LP Heide Van Der","year":"2004","unstructured":"Van Der Heide LP, Hoekman MF, Smidt MP. The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. Biochem J. 2004;380:297\u2013309.","journal-title":"Biochem J"},{"key":"1004_CR30","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nm724","volume":"8","author":"N Maeda","year":"2002","unstructured":"Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, Furuyama N, Kondo H, Takahashi M, Arita Y, et al. Diet-induced insulin resistance in mice lacking adiponectin\/ACRP30. Nat Med. 2002;8:731\u20137.","journal-title":"Nat Med"},{"key":"1004_CR31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.biocel.2016.10.018","volume":"81","author":"J Kim","year":"2016","unstructured":"Kim J, Lee YJ, Kim JM, Lee SY, Bae MA, Ahn JH, Han DC, Kwon BM. PPARgamma agonists induce adipocyte differentiation by modulating the expression of Lipin-1, which acts as a PPARgamma phosphatase. Int J Biochem Cell Biol. 2016;81:57\u201366.","journal-title":"Int J Biochem Cell Biol"},{"key":"1004_CR32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.molmet.2013.11.008","volume":"3","author":"LS Csaki","year":"2014","unstructured":"Csaki LS, Dwyer JR, Li X, Nguyen MH, Dewald J, Brindley DN, Lusis AJ, Yoshinaga Y, de Jong P, Fong L, et al. Lipin-1 and lipin-3 together determine adiposity in vivo. Mol Metab. 2014;3:145\u201354.","journal-title":"Mol Metab"},{"key":"1004_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/oby.2009.198","volume":"18","author":"YC Chang","year":"2010","unstructured":"Chang YC, Chang LY, Chang TJ, Jiang YD, Lee KC, Kuo SS, Lee WJ, Chuang LM. The associations of LPIN1 gene expression in adipose tissue with metabolic phenotypes in the Chinese population. Obesity (Silver Spring). 2010;18:7\u201312.","journal-title":"Obesity (Silver Spring)"},{"key":"1004_CR34","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1194\/jlr.M600272-JLR200","volume":"48","author":"V Harmelen van","year":"2007","unstructured":"van Harmelen V, Ryden M, Sjolin E, Hoffstedt J. A role of lipin in human obesity and insulin resistance: relation to adipocyte glucose transport and GLUT4 expression. J Lipid Res. 2007;48:201\u20136.","journal-title":"J Lipid Res"},{"key":"1004_CR35","doi-asserted-by":"publisher","first-page":"e47813","DOI":"10.1371\/journal.pone.0047813","volume":"7","author":"EJ Dhurandhar","year":"2012","unstructured":"Dhurandhar EJ, Krishnapuram R, Hegde V, Dubuisson O, Tao R, Dong XC, Ye J, Dhurandhar NV. E4orf1 improves lipid and glucose metabolism in hepatocytes: a template to improve steatosis & hyperglycemia. PLoS One. 2012;7:e47813.","journal-title":"PLoS One"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-019-1004-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12944-019-1004-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-019-1004-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T17:49:46Z","timestamp":1606931386000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-019-1004-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,21]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1004"],"URL":"https:\/\/doi.org\/10.1186\/s12944-019-1004-9","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,21]]},"assertion":[{"value":"19 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were conducted according to the ethical guidelines of the Institutional Animal Care and Use Committee of the First Affiliated Hospital of Xinjiang Medical University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"70"}}